Paper

Oxybutynin in detrusor overactivity.

Published Nov 1, 2006 · A. Diokno, Michael S. Ingber

The Urologic clinics of North America

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

Oxybutynin is the "gold standard" for managing detrusor overactivity, reducing urinary frequency and urge urinary incontinence in all age groups and with more dosing flexibility than other anticholinergic medications.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Oxybutynin in detrusor overactivity.

References

Citations